|
2018-10-09
|
Accurate characterization of expanded tandem repeat length and sequence through whole genome long-read sequencing on PromethION.
unknown status
| post
doi:10.1101/439026
|
|
2020-09-12
|
Amyloid-β1–43 cerebrospinal fluid levels and the interpretation of APP, PSEN1 and PSEN2 mutations
published
| stub
| v1
| CC-BY
doi:10.6084/m9.figshare.c.5119628.v1
|
|
2020-09-12
|
Amyloid-β1–43 cerebrospinal fluid levels and the interpretation of APP, PSEN1 and PSEN2 mutations
published
| stub
| CC-BY
doi:10.6084/m9.figshare.c.5119628
|
|
2020-09-12
|
Additional file 1 of Amyloid-β1–43 cerebrospinal fluid levels and the interpretation of APP, PSEN1 and PSEN2 mutations
published
| component
| v1
| CC-BY
doi:10.6084/m9.figshare.12947705.v1
|
|
2020-09-12
|
Additional file 1 of Amyloid-β1–43 cerebrospinal fluid levels and the interpretation of APP, PSEN1 and PSEN2 mutations
published
| component
| CC-BY
doi:10.6084/m9.figshare.12947705
|
|
2021-02-16
|
Reply: Lack of evidence supporting a role for DPP6 sequence variants in Alzheimer's disease in the European American population
published
| article-journal
doi:10.1007/s00401-021-02277-4
|
|
2021-03-28
|
Investigation of the role of matrix metalloproteinases in the genetic etiology of Alzheimer's disease
published
| article-journal
| CC-BY-NC-ND
doi:10.1016/j.neurobiolaging.2021.03.011
|
|
2021-09-10
|
Genetic variants in progranulin upstream open reading frames increase downstream protein expression
published
| article-journal
doi:10.1016/j.neurobiolaging.2021.09.007
|
|
2020-09-11
|
Amyloid-β1–43 cerebrospinal fluid levels and the interpretation of APP, PSEN1 and PSEN2 mutations
published
| article-journal
| CC-BY
doi:10.1186/s13195-020-00676-5
|
|
2023-07-11
|
Mutated Toll-like receptor 9 increases Alzheimer's disease risk by compromising innate immunity protection
published
| article-journal
| CC-BY
doi:10.1038/s41380-023-02166-0
|